TABLE 1.

Clinical parameters of 17 women subjects.

Clinical	Pear subjects	Apple subjects	p-value
parameters	(n = 7)	(n = 10)
Adiposity markers
BMI (kg/m2)	27.4 ± 2.62	28.5 ± 3.74	0.58
Weight (kg)	73 ± 8.8	77 ± 11	0.55
Waist circumference (cm)	80.7 ± 6.03	94.4 ± 8.44	0.003
Hip circumference (cm)	108.1 ± 6.16	107.3 ± 10.5	0.81
Thigh circumference (cm)	60.2 ± 4.58	60.0 ± 5.06	> 0.9
Waist to hip ratio	0.75 ± 0.03	0.88 ± 0.04	< 0.0001
Total Fat mass (kg)	29.2 ± 6.65	33.8 ± 9.54	0.36
Total Lean mass (kg)	41.9 ± 5.4	40.6 ± 3.6	0.67
Fat Mass (%)	39.4 ± 6.5	43.2 ± 6.5	0.27
Android Fat mass (kg)	1.8 ± 0.7	2.9 ± 1.2	0.05
Gynoid Fat mass (kg)	5.8 ± 1.1	6.0 ± 1.8	> 0.9
Leg Fat Mass/Total FM	0.46 ± 0.05	0.36 ± 0.05	0.001
Circulating adiponectin (μg/mL)	13.0 ± 6.0	12.1 ± 5.4	0.87
VAT mass (g)	330 ± 296	724 ± 400	0.04
Liver fat (%)	2.0 ± 1.0	3.0 ± 2.0	0.53
IMAT (cm3)	253 ± 113	289 ± 106	0.53
Lipid profile
HDL (mg/dL)	63.1 ± 8.03	63.9 ± 15.2	0.87
LDL (mg/dL)	103 ± 17.5	110 ± 36.6	0.98
VLDL (mg/dL)	14.6 ± 7.72	17.6 ± 5.27	0.11
TGL (mg/dL)	72.3 ± 38.0	88.0 ± 26.2	0.13
Cholesterol (mg/dL)	181 ± 19.3	192 ± 38.2	0.86
Non-HDL chol (mg/dL)	117 ± 22.5	128 ± 38.4	0.87
Chol/HDL	2.93 ± 0.60	3.12 ± 0.78	0.65
LDL/HDL	1.64 ± 0.43	1.84 ± 0.70	0.55
FFA (μmol/L)	458 ± 178	482 ± 145	0.87
Glucose profile
Fasting Glucose (mg/dL)	85.1 ± 6.54	89.1 ± 5.97	0.29
Fasting Insulin [μ(iU)/mL]	6.53 ± 3.71	7.46 ± 3.00	0.40
HOMA-IR	1.38 ± 0.84	1.66 ± 0.72	0.47
HgbA1c (%)	5.33 ± 0.41	5.20 ± 0.24	0.40
C-peptide (ng/mL)	1.20 ± 0.40	1.30 ± 0.38	0.69
Metabolic markers/hormones
Age (years)	33 ± 8.1	35 ± 6.7	0.74
Testosterone (ng/dL)	32.3 ± 21.5	27.8 ± 14.8	0.81
CRP (mg/L)	3.34 ± 3.60	3.02 ± 1.64	0.74

Mean ± Standard deviation. Non-parametric Mann-Whitney test p ≤ 0.05.